In contrast, GC patients with overexpression of AKR1B10 were found to have advanced lymph node metastasis, fewer tumor regression, and worse overall survival (OS) than those without AKR1B10 expression [25]. This evidence concerns the gene AKR1B10 and metastatic malignant neoplasm in the lymph nodes.